Juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder

Biogenic Amines

Volumn 17, Issue 4-6, 2003, Pages 293-312

  Ueno, Ken Ichi ^a   Togashi, Hiroko ^a   Matsumoto, Machiko ^a   Saito, Hideya ^b   Yoshioka, Mitsuhiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Department of Health Sciences   (Japan)

Author keywords

Attention deficit hyperactivity disorder (AD HD); Elevated plus maze; Methylphenidate; Open field; Stroke prone spontaneously hypertensive rats (SHRSP); Y maze

Indexed keywords

METHYLPHENIDATE;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ATTENTION DEFICIT DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG RESPONSE; EMOTION; FEMALE; HYPERACTIVITY; IMPULSIVENESS; MALE; MAZE TEST; MOBILIZATION; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TEST; NONHUMAN; PATHOGENESIS; RAT; REARING; REVIEW; SEX DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; WORKING MEMORY;

ANIMALIA;

EID: 0141481119     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: 10.1163/15693910260698267     Document Type: Review

References (84)

1. Aman, M. G., Marks, R. E., Turbott, S. H., Wilsher, et al. (1991). Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance, J. Am. Acad. Child Adolesc. Psychiatry 30, 816-824.
2. American Psychiatric Association (1994). Attention-deficit and disruptive behavior disorders, in: Diagnostic and Statistical Manual of Mental Disorders, pp. 78-85. DSM-IV, APA, Washington, DC.
3. Barkley, R. A. (1990). Attention deficit hyperactivity disorder, in: A Handbook for Diagnosis and Treatment, Barkley, R. A. (Ed.), pp. 135-137. Guilford Press, New York.
4. Barkley, R. A. (1998). Attention-deficit hyperactivity disorder, Sci. Am. 279, 43-50.
5. Barkley, R. A., Grodzinsky, G. and DuPaul, G. J. (1992). Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report, J. Abnorm. Child Psychol. 20, 163-188.
6. Berger, D. F. and Sagvolden, T. (1998). Sex differences in operant discrimination behaviour in an animal model of attention-deficit hyperactivity disorder, Behav. Brain Res. 94, 73-82.
7. Bliss, T. V. and Lømo, T. (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path, J. Physiol. 232, 331-356.
8. Bradley, C. (1937). The behavior of children receiving Benzedrine, Am. J. Psychiatry 94, 577-585.
9. Bull, E., Reavill, C., Hagan, J. J., et al. (2000). Evaluation of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder: acquisition and performance of the DRL-60s test, Behav. Brain Res. 109, 27-35.
10. Burgess, J. R., Stevens, L., Zhang, W., et al. (2000). Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder, Am. J. Clin. Nutr. 71 (Suppl.), 327S-330S.
11. Cierpial, M. A., Shasby, D. E., Murphy, C. A., et al. (1989). Open-field behavior of spontaneously hypertensive and Wistar-Kyoto normotensive rats: effects of reciprocal cross-fostering, Behav. Neural Biol. 51, 203-210.
12. Colquhoun, I. and Bunday, S. (1981). A lack of essential fatty acids as a possible cause of hyperactivity in children, Med. Hypotheses 7, 673-679.
13. Comings, D. E. (1993). Serotonin and the biochemical genetics of alcoholism: lessons from studies of attention deficit hyperactivity disorder (ADHD) and Tourette syndrome, Alcohol 2 (Suppl.), 237-241.
14. Conners, C. K. and Eisenberg, L. (1963). The effects of methylphenidate on symptomatology and learning in disturbed children, Am. J. Psychiatry 120, 458-464.
15. Dougherty, D. D., Bonab, A. A., Spencer, T. J., et al. (1999). Dopamine transporter density in patients with attention deficit hyperactivity disorder, Lancet 354, 2132-2133.
16. Evenden, J. and Meyerson, B. (1999). The behavior of spontaneously hypertensive and Wistar-Kyoto rats under a paced fixed consecutive number schedule of reinforcement, Pharmacol. Biochem. Behav. 63, 71-82.
17. Fader, A. J., Johnson, P. E. and Dohanich, G. P. (1999). Estrogen improves working but not reference memory and prevents amnestic effects of scopolamine of a radial-arm maze, Pharmacol. Biochem. Behav. 62, 711-717.
18. Fischer, W., Wictorin, K., Bjorklund, A., et al. (1987). Amelioration of cholinergic neuron strophy and spatial memory impairment in aged rats by nerve growth factor, Nature 329, 65-68.
19. Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., et al. (1999). Role of serotonin in the paradoxical calming effect of psychomotor stimulants on hyperactivity, Science 283, 397-401.
20. Gerasimov, M. R., Franceschi, M., Volkow, N. D., et al. (2000). Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study, J. Pharmacol. Exp. Ther. 295, 51-57.
21. Ghuman, J. K., Ginsburg, G. S., Subramaniam, G., et al. (2001). Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: clinical evidence from a developmental disorder institution, J. Am. Acad. Child Adolesc. Psychiatry 40, 516-524.
22. Giros, B., Jaber, M., Jones, S. R., et al. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter, Nature 379, 606-612.
23. Greiner, R. S., Moriguchi, T., Hutton, A., et al. (1999). Rats with low levels of brain docosahexaenoic acid show impaired performance in olfactory-based and spatial learning tasks, Lipids 34 (Suppl.), S239-S243.
24. Gustafsson, P., Thernlund, G., Ryding, E., et al. (2000). Associations between cerebral blood-flow measured by single photon emission computed tomography (SPECT), electro-encephalogram (EEG), behaviour symptoms, cognition and neurological soft signs in children with attention-deficit hyperactivity disorder, Acta Paediatr. 89, 830-835.
25. Handen, B. L., Feldman, H. M., Lurier, A., et al. (1999). Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD, J. Am. Acad. Child Adolesc. Psychiatry 38, 805-812.
26. Hendley, E. D., Wessel, D. J. and Van Houten, J. (1986). Inbreeding of Wistar-Kyoto rat strain with hyperactivity and without hypertension, Behav. Neural Biol. 45, 1-16.
27. Hibbeln, J. R., Umhau, J. C., George, D. T., et al. (2000). Plasma total cholesterol concentrations do not predict cerebrospinal fluid neurotransmitter metabolites: implications for the biophysical role of highly unsaturated fatty acids, Am. J. Clin. Nutr. 71 (Suppl.), 331S-338S.
28. Honer, W. G., Prohovnik, I., Smith, G., et al. (1988). Scopolamine reduces frontal cortex perfusion, J. Cereb. Blood Flow Metab. 8, 635-641.
29. Hornig, M. (1998). Addressing comorbidity in adults with attention-deficit/hyperactivity disorder, J. Clin. Psychiatry 59 (Suppl. 7), 69-75.
30. Ikemoto, A., Nitta, A., Furukawa, S., et al. (2000). Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus, Neurosci. Lett. 285, 99-102.
31. Katz, R. J. and Schmaltz, K. (1980). Dopaminergic involvement in attention: a novel animal model, Prog. Neuropsychopharmacol. 4, 585-590.
32. Kempton, S., Vance, A., Maruff, P., et al. (1999). Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children, Psychol. Med. 29, 527-538.
33. Kimura, S. (2000). Antihypertensive effect of docosahexaenoic acid in stroke-prone spontaneously hypertensive rats, Yakugaku Zasshi (in Japanese) 120, 607-619.
34. King, J. A., Barkley, R. A., Delville, Y., et al. (2000). Early androgen treatment decreases cognitive function and catecholamine innervation in an animal model of ADHD, Behav. Brain Res. 107, 35-43.
35. Knardahl, S. and Sagvolden, T. (1979). Open-field behavior of spontaneously hypertensive rats, Behav. Neural Biol. 27, 187-200.
36. Kostrzewa, R. M., Brus, R., Kalbfleisch, J. H., et al. (1994). Proposed animal model of attention deficit hyperactivity disorder, Brain Res. Bull. 34, 161-167.
37. Krause, K. H., Dresel, S. H., Krause, J., et al. (2000). Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography, Neurosci. Lett. 285, 107-110.
38. Kruesi, M. J. P., Rapoport, J. L., Hamburger, S., et al. (1990). Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents, Arch. Gen. Psychiatry 47, 419-426.
39. Lahey, B. B., Applegate, B., McBurnett, K., et al. (1994). DSM-IV field trials for attention deficit hyperactivity disorder in children and Adolescents, Am. J. Psychiatry 151, 1673-1685.
40. Lou, H. C., Henriksen, L., Bruhn, P., et al. (1989). Striatal dysfunction in attention deficit and hyperkinetic disorder, Arch. Neurol. 46, 48-52.
41. Luthman, J., Fredriksson, A., Lewander, T., et al. (1989). Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment, Psychopharmacology 99, 550-557.
42. Minami, M., Togashi, H., Koike, Y., et al. (1985). Changes in ambulation and drinking behavior related to stroke in stroke-prone spontaneously hypertensive rats, Stroke 16, 44-48.
43. Minami, M., Kimura, S., Endo, T., et al. (1997). Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats, Pharmacol. Biochem. Behav. 58, 1123-1129.
44. Mitchell, E. A., Aman, M. G., Turbott, S. H., et al. (1987). Clinical characteristics and serum essential fatty acid levels in hyperactive children, Clin. Pediatr. 26, 406-411.
45. Mori, K., Togashi, H., Ueno, K.-i., et al. (2001). Aminoguanidine prevented the impairment of learning behavior and hippocampal long-term potentiation following transient cerebral ischemia, Behav. Brain Res. 120, 159-168.
46. Myers, M. M., Musty, R. E. and Hendley, E. D. (1982). Attenuation of hyperactivity in the spontaneously hypertensive rat by amphetamine, Behav. Neural Biol. 34, 42-54.
47. Nakamura, K., Shirane, M. and Koshikawa, N. (2001). Site-specific activation of dopamine and serotonine transmission by aniracetam in the mesocorticolimbic pathway of rats, Brain Res. 897, 82-92.
48. Nakao, K., Ikegaya, Y., Yamada, M. K., et al. (2001). Spatial performance correlates with long-term potentiation of the dentate gyrus but not of the CA1 region in rats with fimbria-fornix lesions, Neurosci. Lett. 307, 159-162.
49. Okamoto, K. and Aoki, K. (1963). Development of a strain of spontaneously hypertensive rat, Jap. Circ. J. 27, 282-293.
50. Okamoto, K., Yamori, Y. and Nagaoka, A. (1974). Establishment of the stroke-prone spontaneously hypertensive rat (SHR), Circ. Res. 34/35 (Suppl. I), 143-153.
51. Parada-Turska, J. and Turski, W. A. (1990). Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-d-aspartate receptors in learning and memory tasks, Neuropharmacology 29, 1111-1116.
52. Pellow, S. and File, S. E. (1986). Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat, Pharmacol. Biochem. Behav. 24, 525-529.
53. Pellow, S., Chopin, P., File, S. E., et al. (1985). Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat, J. Neurosci. Methods 14, 149-167.
54. Pliszka, S. R. (1989). Effect of anxiety on cognition, behavior, and stimulant response in ADHD, J. Am. Acad. Child Adolesc. Psychiatry 28, 882-887.
55. Pliszka, S. R., McCracken, J. T. and Maas, J. W. (1996). Catecholamines in attention-deficit hyperactivity disorder: current perspectives, J. Am. Acad. Child Adolesc. Psychiatry 35, 264-272.
56. Powell, A. L., Yudd, A., Zee, P., et al. (1997). Attention deficit hyperactivity disorder associated with orbitofrontal epilepsy in a father and a son, Neuropsychiatry Neuropsychol. Behav. Neurol. 10, 151-154.
57. Prohovnik, I., Arnold, S. E., Smith, G., et al. (1997). Physostigmine reversal of scopolamine-induced hypofrontality, J. Cereb. Blood Flow Metab. 17, 220-228.
58. Rapport, M. D., Carlson, G. A., Kelly, K. L., et al. (1993). Methylphenidate and desipramine in hospitalized children: separate and combined effects on cognitive function, J. Am. Acad. Child Adolesc. Psychiatry 32, 333-342.
59. Russell, V., de Villiers, A., Sagvolden, T., et al. (1995). Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder - the spontaneously hypertensive rat, Brain Res. 676, 343-351.
60. Sagvolden, T. (2000). Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD), Neurusci. Biobehav. Rev. 24, 31-39.
61. Sagvolden, T. and Berger, D. F. (1996). An animal model of attention deficit disorders: The female shows more behavioral problems and is more impulsive than the male, Eur. Psychologist 1, 113-122.
62. Sagvolden, T., Metzger, M. A., Schiorbeck, H. K., et al. (1992). The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants, Behav. Neural Biol. 58, 103-112.
63. Sagvolden, T., Metzger, M. A. and Sagvolden, G. (1993a). Frequent reward eliminates differences in activity between hyperkinetic rats and controls, Behav. Neural Biol. 59, 225-229.
64. Sagvolden, T., Pettersen, M. B. and Larsen, M. C. (1993b). Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rats strains, Physiol. Behav. 54, 1047-1055.
65. Sarter, M., Bodewitz, G. and Stephens, D. N. (1988). Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist β-carbolines, Psychopharmacology 94, 491-495.
66. Saul, R. C. and Ashby, C. D. (1986). Measurement of whole blood serotonin as a guide in prescribing psychostimulant medication for children with attentional deficits, Clin. Neuropharmacol. 9, 189-195.
67. Schweitzer, J. B., Faber, T. L., Grafton, S. T., et al. (2000). Alternations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder, Am. J. Psychiatry 157, 278-280.
68. Seeman, P. and Madras, B. K. (1998). Anti-hyperactivity medication: methylphenidate and amphetamine, Mol. Psychiatry 3, 386-396.
69. Spivak, B., Vered, Y., Yoran-Hegesh, R., et al. (1999). Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder, Acta Psychiat. Scand. 99, 300-304.
70. Stevens, L. J., Zentall, S. S., Deck, J. L., et al. (1995). Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder, Am. J. Clin. Nutr. 62, 761-768.
71. Sykes, D. H., Douglas, V. I., Weiss, G., et al. (1971). Attention in hyperactive children and the effect of methylphenidate (ritalin), J. Child Psychol. Psychiatry 12, 129-139.
72. Szatmari, P., Boyle, M. N. and Offord, D. R. (1989). ADHD and conduct disorder: degree of diagnostic overlap and differences among correlates, J. Am. Acad. Child Adolesc. Psychiatry 28, 865-872.
73. Tannock, R., Ickowicz, A. and Schachar, R. (1995). Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety, J. Am. Acad. Child Adolesc. Psychiatry 34, 886-896.
74. Taylor, E. (1998). Clinical foundations of hyperactivity research, Behav. Brain Res. 94, 11-24.
75. Togashi, H., Minami, M., Bando, Y, et al. (1982). Effects of clonidine and guanfacine on drinking and ambulation in spontaneously hypertensive rats, Pharmacol. Biochem. Behav. 17, 519-522.
76. Togashi, H., Matsumoto, M., Yoshioka, M., et al. (1994). Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats, Neurosci. Lett. 166, 117-120.
77. Togashi, H., Kimura, S., Matsumoto, M., et al. (1996). Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats, Stroke 27, 520-526.
78. Tsuda, K., Tsuda, S., Masuyama, Y., et al. (1991). Alteration in catecholamine release in the central nervous system of spontaneously hypertensive rats, Jpn. Heart J. 32, 701-709.
79. Tsukada, H., Kakiuchi, T., Fukumoto, D., et al. (2000). Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys, Brain Res. 862, 180-186.
80. Watanabe, Y., Fujita, M., Ito, Y., et al. (1997). Brain dopamine transporter in spontaneously hypertensive rats, J. Nucl. Med. 38, 470-474.
81. Weiss, G. (1996). Attention deficit hyperactivity disorder, in: Child and Adolescent Psychiatry: A Comprehensive Textbook, 2nd edn, Lewis, M. (Ed.), pp. 544-563. Williams and Wilkins, Baltimore, MD, USA.
82. Wultz, B., Sagvolden, T., Moser, E. I., et al. (1990). The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior, Behav. Neural Biol. 53, 88-102.
83. Yamada, K., Tanaka, T., Zou, L. B., et al. (1999). Long-term deprivation of oestrogens by ovariectomy potentiates beta-amyloid-induced working memory deficits in rats, Br. J. Pharmacol. 128, 419-427.
84. Yamori, Y. and Horie, R. (1977). Developmental course of hypertension and regional cerebral blood flow in stroke-prone spontaneously hypertensive rats, Stroke 8, 456-461.